Loïc Maurel is Medical Doctor and cumulates 30 years of senior management experience in tier-one pharmaceutical, biotech and Diagnostics companies. As the CEO of the Diaxonhit Group (now Eurobio Scientific), Loïc inspired and led the transformation of a pure biotech company, into a full fledge commercial IVD company, following the acquisition of Ingen BioSciences and […]
RENNES, FRANCE— November 04, 2020 DIAFIR, a medical technology company focused on the development, manufacture and sale of innovative diagnostic solutions, today announced that an abstract has been selected for poster presentation during the upcoming The Liver Meeting Digital Experience™ 2020, organized by the American Association for the Study of Liver Disease (AASLD) on November […]
Jean-David Albert, Maëna Le Corvec, Olivia Berthoud, Claire David, Xavier Guennoc, Emmanuel Hoppe, Sandrine Jousse-Joulin, Benoît Le Goff, Hugues Tariel, Olivier Sire… The aim of this study was to show the usefulness of a mid-infrared fibre evanescent wave spectroscopy point of care device in the identification of septic arthritis patients in a multicentre cohort, and to apply this technology to clinical practice among physicians. […]
The study is progressing rapidly, in line with the roadmap, and all results are expected in the third quarter of 2020. RENNES, FRANCE— October 9, 2019 DIAFIR, medical technology company focused on the development, manufacture and sale of innovative diagnostic solutions today announced the initiation and recruitment of the first patients of the clinical study […]
Today, clinicians rely on a liver biopsy to identify and diagnose non-alcoholic steatohepatitis (NASH). In order to improve the management of patients, the development of a non-invasive screening tool appears to be necessary. That is why DIAFIR and hepatologists at the CHU of Angers are working together to clinically validate a non-invasive NASH test, based on […]
RENNES, FRANCE — March, 29 2019 — DIAFIR, a medical technology company focused on the development, manufacture and sale of innovative diagnostic solutions in nonalcoholic steatohepatitis (NASH) and septic arthritis announces today the appointment of Mr Richard Guillaume to its Board of Directors Mr Guillaume has a wide experience of over 30 years in international […]
DIAFIR will be in Vienna from April 10-14, 2019 for the annual EASL International Liver Disease Conference. EASL (European Association for the Study of the Liver) is a medical association dedicated to the pursuit of excellence in the field of liver research, the clinical practice of liver disorders and training. Its goal is to spread […]
This year Diafir will still travel a lot. Our next dates of congress and participation in scientific events. 10-14 Avril 2019 : EASL, Vienne, Autriche 14-16 Mai 2019 : MedTech Europe, Paris, France 5-7 Juin 2019 : National Infectiology Day, Lyon, France 12-15 Juin 2019 : EULAR, Madrid, Espagne 11-12 Juillet 2019 : NASH Symposium, Paris, France 8-12 Novembre 2019 : […]
The fourth event of the Photonic Roadshow was held in Marseille on November 17th. It is an understatement that the meetings were rich. Experts from all countries covered a wide range of topics ranging from medical market trends and needs to photonic technologies, to the transformation of regulatory requirements into value added for products. We […]
Diafir will be present at the next Bio-Europe convention which will take place in Copenhagen from 5 to 7 November 2018. The 24th edition of BIO-Europe is Europe’s largest partnership conference serving the global biotechnology sector. This year’s BIO-Europe Partnership Event will bring together more than 4,000 participants from more than 60 countries, representing more […]
DIAFIR will be present from 3 to 6 October in Lyon at the scientific days of the AFEF (French Society for the Study of the Liver).
The NASH Education Program will launch the 1 st International NASH Day on June 12, 2018, a non-partisan and transversal initiative considered as a key milestone for the whole
